Stage I Non‐Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement

A., Estivill, X., Ferrando, A.A., Gelp ı, J.L., Gonz alez, B., Gonz alez, S., Gonz alez, M., Gut, M., Hern andez-Rivas, J.M., L opez-Guerra, M., Mart ın-Garc ıa, D., Navarro, A., Nicol as, P., Orozco, M., Payer, A.R., Pinyol, M., Pisano, D.G., Puente, D.A., Queir os, A.C., Quesada, V., Romeo-Casabona, C.M., Royo, C., Royo, R., Rozman, M., Russi~ nol, N., Salaverr ıa, I., Stamatopoulos, K., Stunnenberg, H.G., Tamborero, D., Terol, M.J., Valencia, A., L opez-Bigas, N., Torrents, D., Gut, I., L opez-Guillermo, A., L opez-Ot ın, C. & Campo, E. (2015) Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature, 526, 519–524. Sulima, S.O., Hofman, I.J.F., De Keersmaecker, K. & Dinman, J.D. (2017) How ribosomes translate cancer. Cancer Discovery, 7, 1069–1087.